LG Chem shortlists firms for sale of vitro diagnostic business
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
According to sources on Tuesday, Glenwood Private Equity, STIC Investments, Korea Investment Private Equity and EUM Private Equity were shortlisted for the sale of its medical device business, which could be worth over 100 billion won ($76.12 million).
The shortlisted firms will conduct due diligence for a month before deciding whether to participate in the final bidding, which is scheduled to take place later this month. LG Chem and lead underwriter Samjong KPMG held preliminary bidding last month, with five potential buyers submitting a letter of intent.
LG Chem has been involved in the Korean diagnostic market since 1992, producing diagnostic reagents. It obtained an import license for vitro diagnostic medical devices in 2006 and a manufacturing approval in 2013. The company generated sales of some 40 billion won from the diagnostic business last year, which accounted for about 4 percent of its life sciences division’s total revenue.
The decision to sell the vitro diagnostic business is seen as part of LG Chem’s plans to focus on drug development, which was further supported by its acquisition of Nasdaq-listed AVEO Pharmaceuticals for $571 million in January, while the company was not able to take advantage of its expertise in allergy diagnostics during the pandemic.
Copyright © 매일경제 & mk.co.kr. 무단 전재, 재배포 및 AI학습 이용 금지
- 1300만원 깎아주자 벤츠 외면했다…‘통큰할인’ BMW, 이젠 넘버1 [왜몰랐을카] - 매일경제
- “혼자 나온 여성 바지만 보면”…공포에 떠는 방콕女, 무슨일이 - 매일경제
- 성남 분당 정자교 가드레일·보행로 붕괴...1명 사망 - 매일경제
- [단독]메이플스토리 전설의 유저 ‘번개의신vv’...사기혐의로 檢 송치 - 매일경제
- ‘100원 시절’ 있었는데…세월 흘렀다지만 60배 ‘껑충’ 이 음식의 정체 - 매일경제
- 신용점수 20점 오르면 40만원 준다…채무조정 청년들 ‘솔깃’ - 매일경제
- “현실에 오태식은 없었다”… 제주서 벌어진 부동산 갈취 - 매일경제
- 정부, 다음주부터 누누티비 URL 매일 차단한다 - 매일경제
- 테슬라 아마존 제쳤다...서학개미 한달간 가장 많이 산 의외의 종목 - 매일경제
- 이영표·이동국, 승부조작 사면 파문 책임지고 축협 부회장직 사퇴 - MK스포츠